Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes
Journal Title: AAPS PharmSciTech - Year 2015, Vol 16, Issue 1
Abstract
In previous studies, we developed and characterised multicompartmental microcapsules as a platform for the targeted oral delivery of lipophilic drugs in type 2 diabetes (T2D). We also designed a new microencapsulated formulation of probucol-sodium alginate (PB-SA), with good structural properties and excipient compatibility. The aim of this study was to examine the stability and pH-dependent targeted release of the microcapsules at various pH values and different temperatures. Microencapsulation was carried out using a Büchi-based microencapsulating system developed in our laboratory. Using SA polymer, two formulations were prepared: empty SA microcapsules (SA, control) and loaded SA microcapsules (PB-SA, test), at a constant ratio (1:30), respectively. Microcapsules were examined for drug content, zeta potential, size, morphology and swelling characteristics and PB release characteristics at pH 1.5, 3, 6 and 7.8. The production yield and microencapsulation efficiency were also determined. PB-SA microcapsules had 2.6 ± 0.25% PB content, and zeta potential of −66 ± 1.6%, suggesting good stability. They showed spherical and uniform morphology and significantly higher swelling at pH 7.8 at both 25 and 37°C (p < 0.05). The microcapsules showed multiphasic release properties at pH 7.8. The production yield and microencapsulation efficiency were high (85 ± 5 and 92 ± 2%, respectively). The PB-SA microcapsules exhibited distal gastrointestinal tract targeted delivery with a multiphasic release pattern and with good stability and uniformity. However, the release of PB from the microcapsules was not controlled, suggesting uneven distribution of the drug within the microcapsules.
Authors and Affiliations
Armin Mooranian, Rebecca Negrulj, Hesham S. Al-Sallami, Zhongxiang Fang, Momir Mikov, Svetlana Golocorbin-Kon, Marc Fakhoury, Gerald F. Watts, Vance Matthews, Frank Arfuso, Amanda Lambros, Hani Al-Salami
Keywords
Related Articles
- EP ID EP682187
- DOI 10.1208/s12249-014-0205-9
- Views 95
- Downloads 0
Transcutaneous Peptide Immunotherapy of Japanese Cedar Pollinosis Using Solid-in-Oil Nanodispersion Technology
The online version of this article (doi:10.1208/s12249-015-0333-x) contains supplementary material, which is available to authorized users.
Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances
The purpose of this study was to improve the aqueous solubility, dissolution, and pharmacodynamic properties of a BCS class II drug, ezetimibe (Eze) by preparing ternary cyclodextrin complex systems. We investigated the...
Application of Carrier and Plasticizer to Improve the Dissolution and Bioavailability of Poorly Water-Soluble Baicalein by Hot Melt Extrusion
Baicalein (purity > 95%) was supplied by China Pharmaceutical University, Nanjing, China. Kollidon VA64, Soluplus, Cremophor RH, and Poloxamer 188 were friendly supplied by Basf Auxiliary Chemical...
Effect of Hydrocarbon Chain Length in 1,2-Alkanediols on Percutaneous Absorption of Metronidazole: Toward Development of a General Vehicle for Controlled Release
MTZ was purchased from ZhongAn Pharmaceutical, Tianjin, China. 1,4-Cyclohexanediol was obtained from Sigma-Aldrich (St. Louis, MO, USA). 1,2-Propanediol, 1,2-butanediol, 1,2-pentanediol, and 1,2-hexanediol are readily av...
Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions
Thermal processing technologies continue to gain interest in pharmaceutical manufacturing. However, the types and grades of polymers that can be utilized in common thermal processing technologies, such as hot-melt extrus...